Join us for a TIDES USA Investor Recap Call – May 22, 2025, at 8 am ET
Company Profile
Codexis is a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.
Industry Classifications
Sector
Healthcare
Industry
Biotechnology
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Commercial Physical and Biological Research (8731)
Contact Information
Investor Relations
Codexis, Inc.
Carrie McKim
200 Penobscot Drive
Redwood City, CA 94063
United States
M: 650-421-8399
ir@codexis.com
Transfer Agent
EQ Shareowner Services
1110 Centre Pointe Curve
Suite 101
Mendota Heights, MN 55120-4100
T: 800-468-9716
https://www.shareowneronline.com
Company Contact
Codexis, Inc.
200 Penobscot Drive
Redwood City, California 94063
T: 650-421-8100
media@codexis.com